TenderDekho Logo
GEM

Open Tender for Ethambutol 800 Mg Tab,Everolimus 0.25 Mg Tab,Everolimus 0.5 Mg Tab,Fentanyl 50 Mcg Transdermal Patc in CENTRAL DELHI, DELHI

Bid Publish Date

18-Jun-2025, 9:25 am

Bid End Date

09-Jul-2025, 10:00 am

Progress

Issue18-Jun-2025, 9:25 am
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

7540

Category

Ethambutol 800 Mg Tab

Bid Type

Two Packet Bid

Categories 3

A tender has been published for Indian Army Ethambutol 800 Mg Tab, Everolimus 0. 25 Mg Tab, Everolimus 0. 5 Mg Tab, Fentanyl 50 Mcg Transdermal Patch in CENTRAL DELHI, DELHI. Quantity: 7540 by. Submission Deadline: 09-07-2025 10: 00: 00. Check eligibility and apply.

Documents 7

GeM-Bidding-7979506.pdf

Main Document

Other Documents

OTHER

Other Documents

OTHER

Other Documents

OTHER

Other Documents

OTHER

Buyer uploaded ATC document

ATC

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

🤖 AI-Powered Bidder Prediction

Discover companies most likely to bid on this tender

Live AI
Historical Data

Required Documents

1

Experience Criteria

2

Past Performance

3

Bidder Turnover

4

Certificate (Requested in ATC)

5

OEM Authorization Certificate

6

OEM Annual Turnover

7

Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria

8

the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Frequently Asked Questions

Key insights about DELHI tender market

What are the eligibility requirements for this tender?

The eligibility requirements include being a registered entity recognized by pharmaceutical regulatory bodies, adherence to local and national drug regulations, and a capability to manage large-volume orders effectively. Vendors must also demonstrate compliance with ongoing quality assurance protocols, ensuring product reliability.

What are the required certificates for the submission?

Participants must submit certifications that include GMP certification, along with any other relevant pharmaceutical approvals that validate compliance with quality standards. Documentation supporting safety and efficacy, including clinical trial reports and pharmacological data, must also be provided.

What is the registration process for this tender proposal?

Bidders need to register on the official tender portal, providing necessary details about their enterprise, including business licenses, past performance records, and financial statements. Accurate documentation will be crucial for verification purposes during the evaluation process.

What are the accepted document formats for submissions?

All submissions should be made in electronic format, typically as PDFs or Word documents, unless otherwise specified. Additionally, all documents must be compressed and organized clearly to facilitate ease of review during the evaluation process.

What are the benefits for Micro, Small, and Medium Enterprises (MSEs) bidding on this tender?

MSEs participating in this tender have the advantage of tiered evaluation protocols that may offer favorable consideration. Furthermore, the tender aligns with the Make in India initiative, allowing MSEs to contribute to local procurement efforts and enhance their market position through this opportunity.